Peer-reviewedCC BY-NC-NDKidney medicine
Antialbuminuric Effect of Dapagliflozin Correlates With Urinary Epidermal Growth Factor in Real-World Patients With Diabetic Kidney Disease
7 affiliations
- 1Department of Advanced Medical and Surgery Sciences, Unit of Nephrology, University of Campania Luigi Vanvitelli, Naples, Italy
- 2Department of Precision Medicine, University of Campania Luigi Vanvitelli, Naples, Italy
- 3Department of Medicine, University of Perugia, Perugia, Italy
- 4Department of Biomedical and Clinical Sciences, University of Milano, Milan, Italy
- 5Nephrology, Dialysis and Transplantation Unit, Policlinico San Martino, Genoa, Italy
- 6Department of Medical and Surgical Science, Nephrology, Dialysis and Transplantation Unit, University of Foggia, Foggia, Italy
- 7Fondazione IRCCS Ca’ Grande Ospedale Maggiore Policlinico di Milano, Milan, Italy
Related
- Short-term superiority in proteinuria control with exploratory longitudinal trajectories: finerenone-dapagliflozin combination in non-diabetic kidney disease
- Clinical Outcomes of Topical Recombinant Human Epidermal Growth Factor in Diabetic Foot Ulcers: A Retrospective Single-Centre Cohort Study.
- Short-term clinical efficacy and recorded adverse events of semaglutide combined with dapagliflozin in patients with type 2 diabetes mellitus and chronic kidney disease
- The role of the epidermal growth factor receptor (EGFR/ErbB1) in diabetic retinopathy and its therapeutic implications.
- Real-World Renal Effects of Dapagliflozin in Bulgarian Patients with Chronic Kidney Disease of Predominantly Glomerular Origin: A Two-Year Comparative Cohort Study with Historical Controls
BibTeX
@article{borrelli2026antialbuminuric,
title = {{Antialbuminuric Effect of Dapagliflozin Correlates With Urinary Epidermal Growth Factor in Real-World Patients With Diabetic Kidney Disease}},
author = {Silvio Borrelli and Annapaola Coppola and Chiara Ruotolo and Carlo Garofalo and Diego Ingrosso and Federica Marzano and Mariadelina Simeoni and Gianpaolo Reboldi and Alessio Mazzieri and Luca Della Volpe and Maurizio Gallieni and Maura Ravera and Giovanni Stallone and Valeria Gismondi and Giuseppe Castellano and Simone Vettoretti and Roberto Minutolo and Luca De Nicola},
journal = {Kidney medicine},
year = {2026},
month = sep,
doi = {10.1016/j.xkme.2026.101529},
url = {https://europepmc.org/article/PMC/PMC13721090},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Antialbuminuric Effect of Dapagliflozin Correlates With Urinary Epidermal Growth Factor in Real-World Patients With Diabetic Kidney Disease
AU - Silvio Borrelli
AU - Annapaola Coppola
AU - Chiara Ruotolo
AU - Carlo Garofalo
AU - Diego Ingrosso
AU - Federica Marzano
AU - Mariadelina Simeoni
AU - Gianpaolo Reboldi
AU - Alessio Mazzieri
AU - Luca Della Volpe
AU - Maurizio Gallieni
AU - Maura Ravera
AU - Giovanni Stallone
AU - Valeria Gismondi
AU - Giuseppe Castellano
AU - Simone Vettoretti
AU - Roberto Minutolo
AU - Luca De Nicola
PY - 2026
DA - 2026/09/11
JO - Kidney medicine
DO - 10.1016/j.xkme.2026.101529
UR - https://europepmc.org/article/PMC/PMC13721090
SN - 2590-0595
ER -